Lars Erik Vølund Kristensen

Lars Erik Vølund Kristensen

Clinical Professor


Publication year:
All
1 - 25 out of 110Page size: 25
  1. 2024
  2. E-pub ahead of print

    Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: A Danish population-based cohort study

    Hansen, R. L., Jørgensen, T. S., Egeberg, Alexander, Rosenø, N. A. L., Skougaard, M., Stisen, Z. R., Dreyer, L. & Kristensen, Lars Erik Vølund, 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients

    Skougaard, M., Søndergaard, M. F., Ditlev, S. B. & Kristensen, Lars Erik Vølund, 2024, In: International Journal of Molecular Sciences. 25, 5, 15 p., 3002.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. E-pub ahead of print

    Tolerability and comparative effectiveness of TNF-, IL-17-, and IL-23(p19) inhibitors in psoriatic arthritis: A target trial emulation study

    Stisen, Z. R., Nielsen, S. M., Skougaard, M., Mogensen, Mette, Jørgensen, T. S., Dreyer, L., de Wit, M., Christensen, R. & Kristensen, Lars Erik Vølund, 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2023
  6. Published

    Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

    Kristensen, Lars Erik Vølund, Strober, B., Poddubnyy, D., Leung, Y., Jo, H., Kwok, K., Vranic, I., Fleishaker, D. L., Fallon, L., Yndestad, A. & Gladman, D. D., 2023, In: Therapeutic Advances in Musculoskeletal Disease. 15, 17 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study

    Harboe, Z. B., Roed, C., Holler, J. G., Khan, F. I., Abdulrahman, A. N. A., Mulverstedt, S. L., Lindgaard-Jensen, B., Bertelsen, B. B., Søborg, C., Nielsen, T. L., Hansen, L. V., Madsen, B. L., Browatzki, A., Eiberg, M., Bernhard, P. H., Pedersen, E. M. J., Egelund, G. B., Dungu, A. M., Sejdic, A., Mathiesen, I. H. M. & 56 others, Jespersen, N. Z., Petersen, P. T., Nielsen, L., Jepsen, M. P. G., Pedersen, T. I., Eriksson, R., Seitz-Rasmussen, H. E. S., Bestle, Morten Heiberg, Andersen, H., Skram, U., Skøtt, M. R., Altaraihi, S., Sivapalan, P., Jensen , Jens-Ulrik Stæhr , Bagge, K., Jørgensen, K. M., Knudsen, M. J. S., Leineweber, T., Schneider, Uffe Vest, Ahlstrom, M. G., Rytter, S., Le Dous, N., Ravn, P., Reiter, N., Podlekareva, D., Knudsen, A., Johnsen, Stine, Kristensen, Lars Erik Vølund, Leding, C., Hertz, B. B., Benfield, Thomas, Kirk, Ole, Holler, J. G., Ostrowski, Sisse Rye, Sigurdsson, S. T., Perner, Anders, Kirkby, N., Pedersen, M. S., Van Wijhe, M., Simonsen, L., Bager, P. M., Krause, T. G., Voldstedlund, M., Christiansen, L. E., Stegger, M., Cohen, A., Fonager, J., Fomsgaard, A., Legarth, R., Rasmussen, M., Gubbels, S., Wohlfahrt, J., Lillebaek, Troels, Johannesen, C. K., Van Wijhe, M. & Fischer, Thea Kølsen, 2023, In: PLoS ONE. 18, 4 , 15 p., e0282806.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors

    Skougaard, M., Ditlev, S. B., Søndergaard, M. F. & Kristensen, Lars Erik Vølund, 2023, In: International Journal of Molecular Sciences. 24, 7, 16 p., 6343.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study

    Kristensen, Lars Erik Vølund, Keiserman, M., Papp, K., Mccasland, L., White, D., Lu, W., Soliman, A. M., Eldred, A., Barcomb, L. & Behrens, F., 2023, In: Rheumatology (United Kingdom). 62, 6, p. 2113-2121 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

    Skougaard, M., Stisen, Z. R., Jørgensen, T. S., Egeberg, Alexander, Hansen, R. L., Perez-Chada, L. M., Mogensen, Mette, Merola, J. F., Gerwien, J. G. & Kristensen, Lars Erik Vølund, 2023, In: Scandinavian Journal of Rheumatology. 52, 3, p. 259-267

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., White, D., Barcomb, L., Lu, W., Eldred, A. & Behrens, F., 2023, In: Rheumatology (Oxford, England). 62, 2, p. 629-637 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: A Danish population-based cohort study

    Petersen, M. B., Hansen, R. L., Egeberg, Alexander, Jørgensen, T. S., Merola, J. F., Coates, L. C. & Kristensen, Lars Erik Vølund, 2023, In: Rheumatology Advances in Practice. 7, 2, rkad035.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Who are likely to benefit from the Good Life with osteoArthritis in Denmark (GLAD) exercise and education program? An effect modifier analysis of a randomised controlled trial

    Henriksen, Marius, Nielsen, S. M., Christensen, R., Kristensen, Lars Erik Vølund, Bliddal, Henning, Bartholdy, C., Boesen, Mikael Ploug, Ellegaard, K., Hunter, D. J., Altman, R. & Bandak, Elisabeth Ann, 2023, In: Osteoarthritis and Cartilage. 31, 1, p. 106-114

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 2022
  15. Published

    The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., Barcomb, L., Eldred, A. & Östör, A., 1 Nov 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 2120-2129 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study

    Loft, N., Nguyen, T. T., Kristensen, Lars Erik Vølund, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, Mar 2022, In: Journal of the American Academy of Dermatology. 86, 3, p. 590-597 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Is Real-world Evidence Really Real?

    Kristensen, Lars Erik Vølund & Egeberg, Alexander, 1 Feb 2022, In: Journal of Rheumatology. 49, 2, p. 126-127 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  18. Published

    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study

    Amris, K., Bandak, Elisabeth Ann, Kristensen, Lars Erik Vølund & Wæhrens, E. E., 2022, In: Scandinavian Journal of Rheumatology. 51, 6, p. 452-460 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., Merola, J. F., Barcomb, L., Wang, Z., Eldred, A. & Behrens, F., 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 5, p. e389-e392

    Research output: Contribution to journal › Letter › Research › peer-review

  20. Published

    Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial

    Reich, K., Kristensen, Lars Erik Vølund, Smith, S. D., Rich, P., Sapin, C., Leage, S. L., McKenzie, R., Schuster, C., Riedl, E. & Gooderham, M., 2022, In: Dermatology Practical and Conceptual. 12, 2, 12 p., e2022104.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

    Kristensen, Lars Erik Vølund, Keiserman, M., Papp, K., McCasland, L., White, D., Lu, W., Wang, Z., Soliman, A. M., Eldred, A., Barcomb, L. & Behrens, F., 2022, In: Annals of the Rheumatic Diseases. 81, 2, p. 225-231 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trial

    Bandak, Elisabeth Ann, Christensen, R., Overgaard, A., Kristensen, Lars Erik Vølund, Ellegaard, K., Guldberg-Møller, J., Bartholdy, C., Hunter, D. J., Altman, R., Bliddal, Henning & Henriksen, Marius, 2022, In: Annals of the Rheumatic Diseases. 81, 4, p. 537-543 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis

    Sagard, J., Olofsson, T., Mogard, E., Marsal, J., Andréasson, K., Geijer, M., Kristensen, Lars Erik Vølund, Lindqvist, E. & Wallman, J. K., 2022, In: Arthritis Research and Therapy. 24, 1, 42.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Identifying and understanding disease burden in patients with inflammatory bowel disease

    Christensen, K. R., Ainsworth, M. A., Skougaard, M., Steenholdt, Casper, Buhl, S., Brynskov, J., Kristensen, Lars Erik Vølund & Jørgensen, T. S., 2022, In: BMJ Open Gastroenterology. 9, 1, 11 p., 000994.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H

    Kristensen, Lars Erik Vølund, Okada, M., Tillett, W., Leage, S. L., El Baou, C., Sapin, C., Bradley, A. J., Meszaros, G., Dutz, J. P. & de Vlam, K., 2022, In: Rheumatology and Therapy. 9, p. 109-125 17 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis

    Reich, K., Conrad, C., Kristensen, Lars Erik Vølund, Smith, S. D., Puig, L., Rich, P., Sapin, C., Holzkaemper, T., Koppelhus, U. & Schuster, C., 2022, In: Journal of Dermatological Treatment. 33, 3, p. 1652-1660 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Response to: 'Correspondence on: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.

    Wallman, J. K., Mogard, E., Marsal, J., Andréasson, K., Jöud, A., Geijer, M., Kristensen, Lars Erik Vølund, Lindqvist, E. & Olofsson, T., 2022, In: Annals of the Rheumatic Diseases. 81, 1, 216752.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  28. Published

    Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3

    Egeberg, Alexander, Kristensen, Lars Erik Vølund, Vender, R., Zaheri, S., El Baou, C., Gallo, G., Riedl, E. & Schuster, C., 2022, In: Acta Dermato-Venereologica. 102, 4 p., adv00787.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 164256855